| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MRK | Common Stock | Options Exercise | $58.3K | +824 | +1.99% | $70.71 | 42.1K | Feb 2, 2024 | Direct | |
| transaction | MRK | Common Stock | Options Exercise | $2.37M | +32.2K | +76.34% | $73.73 | 74.3K | Feb 2, 2024 | Direct | |
| transaction | MRK | Common Stock | Sale | -$6.42M | -50.7K | -68.22% | $126.65 | 23.6K | Feb 2, 2024 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MRK | Stock Option (Right to Buy) | Options Exercise | $0 | -824 | -100% | $0.00* | 0 | Feb 2, 2024 | Common Stock | 824 | $70.71 | Direct | F2 |
| transaction | MRK | Stock Option (Right to Buy) | Options Exercise | $0 | -32.2K | -59.29% | $0.00 | 22.1K | Feb 2, 2024 | Common Stock | 32.2K | $73.73 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.4300 to $126.9000, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F2 | The option vested and became exercisable in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021. |
| F3 | The option vests and becomes exercisable in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024. |